336 related articles for article (PubMed ID: 31651327)
1. Enhanced Bruton's tyrosine kinase in B-cells and autoreactive IgA in patients with idiopathic pulmonary fibrosis.
Heukels P; van Hulst JAC; van Nimwegen M; Boorsma CE; Melgert BN; von der Thusen JH; van den Blink B; Hoek RAS; Miedema JR; Neys SFH; Corneth OBJ; Hendriks RW; Wijsenbeek MS; Kool M
Respir Res; 2019 Oct; 20(1):232. PubMed ID: 31651327
[TBL] [Abstract][Full Text] [Related]
2. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
[No Abstract] [Full Text] [Related]
3. Aberrant B Cell Receptor Signaling in Naïve B Cells from Patients with Idiopathic Pulmonary Fibrosis.
Neys SFH; Heukels P; van Hulst JAC; Rip J; Wijsenbeek MS; Hendriks RW; Corneth OBJ
Cells; 2021 May; 10(6):. PubMed ID: 34073225
[TBL] [Abstract][Full Text] [Related]
4. Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic pulmonary fibrosis.
Karampitsakos T; Galaris A; Chrysikos S; Papaioannou O; Vamvakaris I; Barbayianni I; Kanellopoulou P; Grammenoudi S; Anagnostopoulos N; Stratakos G; Katsaras M; Sampsonas F; Dimakou K; Manali ED; Papiris S; Tourki B; Juan-Guardela BM; Bakakos P; Bouros D; Herazo-Maya JD; Aidinis V; Tzouvelekis A
Respir Res; 2023 Nov; 24(1):279. PubMed ID: 37964265
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin A in serum: an old acquaintance as a new prognostic biomarker in idiopathic pulmonary fibrosis.
Ten Klooster L; van Moorsel CH; Kwakkel-van Erp JM; van Velzen-Blad H; Grutters JC
Clin Exp Immunol; 2015 Aug; 181(2):357-61. PubMed ID: 25845491
[TBL] [Abstract][Full Text] [Related]
6. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
[TBL] [Abstract][Full Text] [Related]
7. Alveolar epithelial TET2 is not involved in the development of bleomycin-induced pulmonary fibrosis.
Qin W; Crestani B; Spek CA; Scicluna BP; van der Poll T; Duitman J
FASEB J; 2021 May; 35(5):e21599. PubMed ID: 33913570
[TBL] [Abstract][Full Text] [Related]
8. IgA Antibodies Directed Against Citrullinated Protein Antigens Are Elevated in Patients With Idiopathic Pulmonary Fibrosis.
Solomon JJ; Matson S; Kelmenson LB; Chung JH; Hobbs SB; Rosas IO; Dellaripa PF; Doyle TJ; Poli S; Esposito AJ; Visser A; Marin AI; Amigues I; Fernández Pérez ER; Brown KK; Mahler M; Heinz D; Cool C; Deane KD; Swigris JJ; Demoruelle MK
Chest; 2020 Jun; 157(6):1513-1521. PubMed ID: 31877269
[TBL] [Abstract][Full Text] [Related]
9. Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis.
Espindola MS; Habiel DM; Narayanan R; Jones I; Coelho AL; Murray LA; Jiang D; Noble PW; Hogaboam CM
Am J Respir Crit Care Med; 2018 Jun; 197(11):1443-1456. PubMed ID: 29634284
[TBL] [Abstract][Full Text] [Related]
10. Lipocalin-2 as a prognostic marker in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Tanahashi H; Iwamoto H; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Respir Res; 2024 May; 25(1):195. PubMed ID: 38704585
[TBL] [Abstract][Full Text] [Related]
11. The Bleomycin Model of Pulmonary Fibrosis.
Liu T; De Los Santos FG; Phan SH
Methods Mol Biol; 2017; 1627():27-42. PubMed ID: 28836192
[TBL] [Abstract][Full Text] [Related]
12. Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis.
Heukels P; van Hulst JAC; van Nimwegen M; Boorsma CE; Melgert BN; van den Toorn LM; Boomars KAT; Wijsenbeek MS; Hoogsteden H; von der Thüsen JH; Hendriks RW; Kool M; van den Blink B
Respir Res; 2018 May; 19(1):90. PubMed ID: 29747640
[TBL] [Abstract][Full Text] [Related]
13. Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis.
Cárdenes N; Álvarez D; Sellarés J; Peng Y; Corey C; Wecht S; Nouraie SM; Shanker S; Sembrat J; Bueno M; Shiva S; Mora AL; Rojas M
Stem Cell Res Ther; 2018 Sep; 9(1):257. PubMed ID: 30257725
[TBL] [Abstract][Full Text] [Related]
14. Quercetin Enhances Ligand-induced Apoptosis in Senescent Idiopathic Pulmonary Fibrosis Fibroblasts and Reduces Lung Fibrosis In Vivo.
Hohmann MS; Habiel DM; Coelho AL; Verri WA; Hogaboam CM
Am J Respir Cell Mol Biol; 2019 Jan; 60(1):28-40. PubMed ID: 30109946
[TBL] [Abstract][Full Text] [Related]
15. Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis.
O'Dwyer DN; Ashley SL; Gurczynski SJ; Xia M; Wilke C; Falkowski NR; Norman KC; Arnold KB; Huffnagle GB; Salisbury ML; Han MK; Flaherty KR; White ES; Martinez FJ; Erb-Downward JR; Murray S; Moore BB; Dickson RP
Am J Respir Crit Care Med; 2019 May; 199(9):1127-1138. PubMed ID: 30789747
[No Abstract] [Full Text] [Related]
16. Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patients.
Xue J; Kass DJ; Bon J; Vuga L; Tan J; Csizmadia E; Otterbein L; Soejima M; Levesque MC; Gibson KF; Kaminski N; Pilewski JM; Donahoe M; Sciurba FC; Duncan SR
J Immunol; 2013 Sep; 191(5):2089-95. PubMed ID: 23872052
[TBL] [Abstract][Full Text] [Related]
17. B7H3 expression and significance in idiopathic pulmonary fibrosis.
Fang C; Rinke AE; Wang J; Flaherty KR; Phan SH; Liu T
J Pathol; 2022 Mar; 256(3):310-320. PubMed ID: 34825713
[TBL] [Abstract][Full Text] [Related]
18. B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis.
François A; Gombault A; Villeret B; Alsaleh G; Fanny M; Gasse P; Adam SM; Crestani B; Sibilia J; Schneider P; Bahram S; Quesniaux V; Ryffel B; Wachsmann D; Gottenberg JE; Couillin I
J Autoimmun; 2015 Jan; 56():1-11. PubMed ID: 25441030
[TBL] [Abstract][Full Text] [Related]
19. Allies or enemies? The effect of regulatory T cells and related T lymphocytes on the profibrotic environment in bleomycin-injured lung mouse models.
Seyran M; Melanie S; Philip S; Amiq G; Fabian B
Clin Exp Med; 2023 Aug; 23(4):1075-1088. PubMed ID: 36403186
[TBL] [Abstract][Full Text] [Related]
20. The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis.
Hanaka T; Kido T; Noguchi S; Yamada S; Noguchi H; Guo X; Nawata A; Wang KY; Oda K; Takaki T; Izumi H; Ishimoto H; Yatera K; Mukae H
BMC Pulm Med; 2019 Dec; 19(1):265. PubMed ID: 31888585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
